LambrosStamatakisMD

Urology • Washington, DC

Minimally Invasive Surgery, Surgical Oncology

MedStar Washington Hospital Center

Join to view full profile

Dr. Stamatakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stamatakis' full profile

Already have an account?

Office
110 Irving St Nw
Suite 3b-19
Washington, DC 20010
Phone+1 202-877-2252

Summary

Dr. Lambros Stamatakis is an urologist in Washington, DC and is affiliated with MedStar Washington Hospital Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 12 years. He specializes in minimally invasive surgery and surgical oncology and is experienced in urologic oncology and minimally invasive urologic surgery.

Education & Training

National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2012 - 2014
Baylor College of MedicineFellowship, Minimally Invasive Urologic Surgery, 2011 - 2012
Baylor College of MedicineResidency, Urology, 2006 - 2011
Baylor College of MedicineInternship, Transitional Year, 2005 - 2006
University of Maryland School of MedicineClass of 2005

Certifications & Licensure

MD State Medical License 2012 - 2025
DC State Medical License 2014 - 2024
VA State Medical License 2014 - 2016
TX State Medical License 2011 - 2015
American Board of Urology Urology

Publications & Presentations

PubMed

Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).
Daniel M Geynisman, Philip H Abbosh, Eric Ross, Matthew R Zibelman, Pooja Ghatalia
Journal of Clinical Oncology. 2024-12-16
Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis.
Christopher P Dall, James B Mason, Charlotte C Goldman, Grant Fabrizio, Emily C Alagha
Urologic Oncology. 2024-05-01
Economic Outcomes of Hexaminolevulinate Blue-Light Cystoscopy in Non-Muscle Invasive Bladder Cancer: A 5-Year, Medicare-Based Model.
Michael L Creswell, Tamir N Sholklapper, Michael J Markel, James B Mason, Mark A Pianka
Bladder Cancer. 2023-01-01

Authored Content

To Oophorectomy or Not to Oophorectomy: Practice Patterns Among Urologists Treating Bladder CancerDecember 2017

Press Mentions

Some Patients with Bladder Cancer 'Can't Wait' for Treatment During the COVID-19 PandemicMay 21st, 2020
Trump: Melania Can’t Fly for One Month After Big OperationJune 9th, 2018
Melania Had ‘Big Operation,’ Can’t Fly for a Month, Trump RevealsJune 8th, 2018
Join now to see all